ArticleCritical care explorations2026
Substance Use and Delirium Trends in the Critically Ill During the Peri-COVID Period.
Article in Critical care explorations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
importanceSubstance use complicates many hospitalizations by increasing delirium rates, acuity, and costs. Its prevalence rose during the COVID-19 pandemic, potentially contributing to increased delirium in hospitalized patients.
objectivesTo describe trends in substance use and delirium complicating ICU and floor admission around the COVID-19 pandemic and determine whether increased societal substance use was associated with increased prevalence of delirium and substance use in the critically ill. DESIGN, SETTING, AND
participantsRetrospective cohort study using a large deidentified database of patients admitted to the medical ICU and medicine wards at a single U.S. academic center. We used International Classification of Diseases, Tenth Revision (ICD-10) codes for substance use and a validated ICD-based delirium phenotype to identify exposures. MAIN OUTCOMES AND MEASURES: Monthly prevalence of delirium and substance use was calculated in the ICU and on the floor. We performed interrupted time series analysis to determine the effect of the COVID-19 pandemic on these trends.
resultsPre-pandemic, ICU admissions complicated by substance use were declining. The onset of COVID-19 marked a significant reversal, with stepwise continued increase upon entering the recovery phase of the pandemic. Floor admissions complicated by substance use were gradually decreasing pre-pandemic, remained steady during lockdowns, and rose in the recovery phase. ICU delirium prevalence was decreasing pre-pandemic but rose abruptly with the onset of lockdowns, then declined during the pandemic. Delirium prevalence on the floor was increasing before the pandemic and remained stable during the peak and has continued to rise into the recovery phase. CONCLUSIONS AND RELEVANCE: Post-COVID, substance use increased in both ICU and floor admissions. Delirium increased during COVID but has since decreased in the ICU. Prevalence has continued to rise on the floor. Substance use and delirium trends during the COVID-19 pandemic reflect strain on the healthcare system during this time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.